Are You Forfeiting Revenue by Underutilizing Your Outpatient Pharmacy?

An underutilized outpatient retail pharmacy may be responsible for revenue left on the table.

Read time: 2 minutes

By: MHS Editorial Team

The increasing cost pressures on health systems have pushed many to look beyond traditional streams of revenue in order to remain profitable and continue providing a higher standard of care. In recent years, the outpatient pharmacy has emerged as a worthwhile investment for its ability to capture revenue that may otherwise have been missed. Along with discharge prescriptions, the integrated outpatient pharmacy can bring in would-be lost dollars through:

Supporting ambulatory services

This may include dispensing medications for home infusion therapies in order to retain a larger portion of the market – with the home infusion market projected to reach $20.6 billion by 2027.

Specialty medications

Specialty pharmacy may bring in as much as 10% of a health system’s revenue alone.

340B savings

According to the Health Resources and Services Administration (HRSA), enrolled hospitals and covered entities can achieve an average of 25- 50% in savings on pharmaceutical purchases through 340B.

If you feel that your outpatient pharmacy may not be operating at its full potential, McKesson can help.

Find out what other risks you may encounter with an underutilized outpatient pharmacy and learn what solutions McKesson Health Systems has available to help you achieve more by downloading our recent eBook, 3 Costly Risks of Underutilizing Your Outpatient Retail Pharmacy.

To learn more about how McKesson can help you improve the performance of your outpatient pharmacy, you can also contact our McKesson Health Systems experts today.

Subscribe to our monthly Prescribed Perspectives newsletter today to have our exclusive content delivered directly to your inbox!